Martina Fojtíková PhD
Researcher
Research activities
IN VITRO MODELS
METHODS OF MOLECULAR BIOLOGY
TESTING OF ANTIVIRAL ACTIVITY OF NATURAL COMPOUNDS
PRODUCTION OF MONOCLONAL ANTIBODIES
RESEARCH AND DEVELOPMENT OF RECOMBINANT PROTEIN VACCINES
Project involvement
FIT (Pharmacology, Immunotherapy, nanoToxicology)
OP RDE project of the Ministry of Education, Youth and Sports of the Czech Republic – Reg.No. CZ.02.1.01/0.0/0.0/15_003/0000495
CEREBIT (Centre for Recombinant Biotechnologies and Immunotherapeutics)
OP RDE project of the Ministry of Education, Youth and Sports of the Czech Republic – Reg.No. CZ.02.1.01/0.0/0.0/16_025/0007397
Advanced Studies on Pathogenesis of West Nile Fewer towards New Theraputic Strategies
OP RDE project of the Ministry of Education, Youth and Sports of the Czech Republic – Reg.No. CZ.02.2.69/0.0/0.0/16_018/0002665
Education
2012–2019
PhD in Biochemistry, Faculty of Science, Masaryk University Brno, Czech Republic
2010–2012
Master degree (Mgr.), Faculty of Science, Palacky University Olomouc, Czech Republic
2007-2010
Bachelor degree (Bc.), Faculty of Science, Masaryk University Brno, Czech Republic
Internships abroad
2013–2014
King’s College London, UK (5. 3. 2013–13. 2. 2014)
Selected publications
Stefanik M, Valdes JJ, Ezebuo FC, Haviernik J, Uzochukwu IC, Fojtikova M, Salat J, Eyer L, Ruzek D. FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells. Microorganisms. 2020 Apr 20;8(4):599.
Eyer L, Fojtíková M, Nencka R, Rudolf I, Hubálek Z, Ruzek D. Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2′-C-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02093-18.
Zouharova D, Lipenska I, Fojtikova M, Kulich P, Neca J, Slany M, Kovarcik K, Turanek-Knotigova P, Hubatka F, Celechovska H, Masek J, Koudelka S, Prochazka L, Eyer L, Plockova J, Bartheldyova E, Miller AD, Ruzek D, Raska M, Janeba Z, Turanek J. Antiviral activities of 2,6-diaminopurine-based acyclic nucleoside phosphonates against herpesviruses: In vitro study results with pseudorabies virus (PrV, SuHV-1). Vet Microbiol. 2016 Feb 29;184:84-93.